Suchergebnisse - "Oluwole, Olalekan O"

PubPharm (29)

1

Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids

enthalten in: Bone marrow transplantation | 2024

von Oluwole, O. | Forcade, E. | Muñoz, J. | +23

2

Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5)

enthalten in: Blood | 2024

von Neelapu, S. | Chavez, J. | Sehgal, A. | +23

CommentIn: Blood. 2024 Feb 8;143(6):475-476. - PMID 38329775

3

Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome

enthalten in: Blood advances | 2023

von Bhaskar, S. | Patel, V. | Porter, D. | +12

4

Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3

enthalten in: Journal for immunotherapy of cancer | 2023

von Shah, B. | Cassaday, R. | Park, J. | +26

5

Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma

enthalten in: The New England journal of medicine | 2023

von Westin, J. | Oluwole, O. | Kersten, M. | +129

CommentIn: N Engl J Med. 2023 Sep 21;389(12):1152-1153. - PMID 37733322

6

Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy

enthalten in: Blood advances | 2023

von Wudhikarn, K. | Tomas, A. | Flynn, J. | +12

7

Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Westin, J. | Locke, F. | Dickinson, M. | +24

8

Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma

enthalten in: Blood | 2023

von Neelapu, S. | Jacobson, C. | Ghobadi, A. | +27

CommentIn: Blood. 2023 May 11;141(19):2285-2286. - PMID 37166931

9

Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice : Results From the US Lymphoma CAR T Consortium

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Wang, Y. | Jain, P. | Locke, F. | +26

10

Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma

enthalten in: Haematologica | 2023

von Zurko, J. | Ramdial, J. | Shadman, M. | +39